J. Qin, Y. Li, Z. Cai, S. Li, J. Zhu et al., A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, vol.490, issue.7418, pp.55-60, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01204262

P. J. Turnbaugh, M. Hamady, T. Yatsunenko, B. L. Cantarel, A. Duncan et al., A core gut microbiome in obese and lean twins, Nature, vol.457, issue.7228, p.2677729, 2009.

R. E. Ley, F. Backhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight et al., Obesity alters gut microbial ecology, Proc Natl Acad Sci, vol.102, issue.31, pp.11070-11075, 2005.

L. Chatelier, E. Nielsen, T. Qin, J. Prifti, E. Hildebrand et al., Richness of human gut microbiome correlates with metabolic markers, Nature, vol.500, issue.7464, pp.541-547, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01190602

A. Cotillard, S. P. Kennedy, L. C. Kong, E. Prifti, N. Pons et al., Dietary intervention impact on gut microbial gene richness, Nature, vol.500, issue.7464, pp.585-593, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01001543

A. Prifti, E. Belda, E. Ichou, F. Kayser, B. D. Dao et al., Major microbiota dysbiosis in severe obesity: fate after bariatric surgery, Gut, vol.68, issue.1, pp.70-82, 2019.

E. F. Murphy, P. D. Cotter, S. Healy, T. M. Marques, O. O'sullivan et al., Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models, Gut, vol.59, issue.12, pp.1635-1677, 2010.

B. Hippe, M. Remely, E. Aumueller, A. Pointner, U. Magnet et al., Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects, Beneficial microbes, vol.7, issue.4, pp.511-518, 2016.

G. D. Wu, J. Chen, C. Hoffmann, K. Bittinger, Y. Y. Chen et al., Linking long-term dietary patterns with gut microbial enterotypes, Science, vol.334, issue.6052, p.3368382, 2011.

R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, Microbial ecology: human gut microbes associated with obesity, Nature, vol.444, issue.7122, pp.1022-1025, 2006.

X. Wu, C. Ma, L. Han, M. Nawaz, F. Gao et al., Molecular characterisation of the faecal microbiota in patients with type II diabetes, Curr Microbiol, vol.61, issue.1, pp.69-78, 2010.

M. Remely, B. Hippe, J. Zanner, E. Aumueller, H. Brath et al., Gut microbiota of obese, type 2 diabetic individuals is enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after weight loss. Endocrine, metabolic & immune disorders drug targets, 2016.

J. P. Furet, L. C. Kong, J. Tap, C. Poitou, A. Basdevant et al., Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers, Diabetes, vol.59, issue.12, pp.3049-57, 2010.

P. Central and P. , , p.2992765

P. D. Cani, S. Possemiers, T. Van-de-wiele, Y. Guiot, E. A. Rottier et al., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, Gut, vol.58, issue.8, pp.1091-103, 2009.

P. Central and P. , , p.2702831

A. Everard, V. Lazarevic, M. Derrien, M. Girard, G. G. Muccioli et al., Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice, Diabetes, vol.60, issue.11, p.3198091, 2011.

A. Everard, V. Lazarevic, N. Gaia, M. Johansson, M. Stahlman et al., Microbiome of prebiotictreated mice reveals novel targets involved in host response during obesity, ISME J, vol.8, issue.10, p.4163056, 2014.

H. Plovier, A. Everard, C. Druart, C. Depommier, M. Van-hul et al., A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, Nat Med, vol.23, issue.1, pp.107-120, 2017.

M. C. Dao, E. A. Aron-wisnewsky, J. Sokolovska, N. Prifti, E. Verger et al., Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology, Gut, vol.65, issue.3, pp.426-462, 2016.

F. Backhed, H. Ding, T. Wang, L. V. Hooper, G. Y. Koh et al., The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci U S A, vol.101, issue.44, p.524219, 2004.

A. Everard and P. D. Cani, Diabetes, obesity and gut microbiota, Best Pract Res Clin Gastroenterol, vol.27, issue.1, pp.73-83, 2013.

H. Tilg and A. R. Moschen, Microbiota and diabetes: an evolving relationship, Gut, vol.63, issue.9, pp.1513-1534, 2014.

V. Tremaroli and F. Backhed, Functional interactions between the gut microbiota and host metabolism, Nature, vol.489, issue.7415, pp.242-251, 2012.

R. S. Kootte, E. Levin, J. Salojarvi, L. P. Smits, A. V. Hartstra et al., Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition, Cell Metab, vol.26, issue.4, pp.611-620, 2017.

A. Vrieze, E. Van-nood, F. Holleman, J. Salojarvi, R. S. Kootte et al., Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome, Gastroenterology, vol.143, issue.4, pp.913-919, 2012.

F. L. Luan and M. Samaniego, Transplantation in diabetic kidney failure patients: modalities, outcomes, and clinical management, Semin Dial, vol.23, issue.2, pp.198-205, 2010.

S. Palepu and G. V. Prasad, New-onset diabetes mellitus after kidney transplantation: Current status and future directions, World J Diabetes, vol.6, issue.3, p.4398901, 2015.

M. Hecking, J. Werzowa, M. Haidinger, W. H. Horl, J. Pascual et al., Novel views on new-onset diabetes after transplantation: development, prevention and treatment, Nephrol Dial Transplant, vol.28, issue.3, p.4375396, 2013.

K. M. Wissing and L. Pipeleers, Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment, Transplantation reviews, vol.28, issue.2, pp.37-46, 2014.

J. R. Curtis, A. O. Westfall, J. Allison, J. W. Bijlsma, A. Freeman et al., Population-based assessment of adverse events associated with long-term glucocorticoid use, Arthritis and rheumatism, vol.55, issue.3, pp.420-426, 2006.

J. M. Boots, E. M. Van-duijnhoven, M. H. Christiaans, B. H. Wolffenbuttel, and J. P. Van-hooff, Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction, J Am Soc Nephrol, vol.13, issue.1, pp.221-228, 2002.

O. Johnston, C. L. Rose, A. C. Webster, and J. S. Gill, Sirolimus is associated with new-onset diabetes in kidney transplant recipients, J Am Soc Nephrol, vol.19, issue.7, p.2440303, 2008.

H. J. Anders, K. Andersen, and B. Stecher, The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease, Kidney Int, vol.83, issue.6, pp.1010-1016, 2013.

A. Yoshifuji, S. Wakino, J. Irie, T. Tajima, K. Hasegawa et al., Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats, Nephrol Dial Transpl, vol.31, issue.3, pp.401-413, 2016.

J. Tourret, B. P. Willing, S. Dion, J. Macpherson, E. Denamur et al., Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli, Transplantation, vol.101, issue.1, pp.74-82, 2017.

, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes, Diabetes Care, vol.41, issue.1, pp.13-27, 2018.

V. Thomas, J. Clark, and J. Dore, Fecal microbiota analysis: an overview of sample collection methods and sequencing strategies, Future Microbiol, vol.10, issue.9, pp.1485-504, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01535321

X. Zhang, D. Shen, Z. Fang, Z. Jie, X. Qiu et al., Human gut microbiota changes reveal the progression of glucose intolerance, PLoS One, vol.8, issue.8, p.3754967, 2013.

M. Yassour, M. Y. Lim, H. S. Yun, T. L. Tickle, J. Sung et al., Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes, Genome Med, vol.8, issue.1, p.4756455, 2016.

H. Li, J. He, and W. Jia, The influence of gut microbiota on drug metabolism and toxicity. Expert opinion on drug metabolism & toxicology, vol.12, pp.31-40, 2016.

H. Wu, E. Esteve, V. Tremaroli, M. T. Khan, R. Caesar et al., Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug, Nat Med, vol.23, issue.7, pp.850-858, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01608413